|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
67,982,000 |
Market
Cap: |
4.83(M) |
Last
Volume: |
131,023 |
Avg
Vol: |
130,657 |
52
Week Range: |
$0.067 - $0.16 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Wholesale |
Level
III Sector: |
Medical Equipment Wholesale |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile PURE Bioscience develops and commercializes antimicrobial products that provide solutions for pathogen and hygienic control. Co.'s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), which is a non-toxic antimicrobial agent. Co. provides PURE® Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies. Co. also provides PURE Control® as a direct food contact processing aid. In addition, Co. manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
110,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$15,599 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bartlett Robert F |
CEO |
|
2023-03-22 |
4 |
B |
$0.16 |
$7,750 |
I/I |
50,000 |
50,000 |
2.58 |
-24% |
|
Blotner Bernard |
Director |
|
2023-03-21 |
4 |
B |
$0.13 |
$1,299 |
I/I |
10,000 |
10,000 |
2.02 |
-35% |
|
Lee Tom Y |
Chief Executive Officer |
|
2022-12-15 |
4 |
B |
$0.13 |
$6,550 |
D/D |
50,000 |
5,001,843 |
3.15 |
-32% |
|
Lee Tom Y |
Chief Executive Officer |
|
2022-07-15 |
4 |
A |
$0.15 |
$3,261,250 |
I/I |
21,741,666 |
6,000,000 |
|
- |
|
Rendall David |
Director |
|
2022-07-15 |
4 |
A |
$0.15 |
$48,750 |
D/D |
325,000 |
402,371 |
|
- |
|
Chen Ivan |
Director |
|
2022-07-15 |
4 |
A |
$0.15 |
$45,000 |
D/D |
300,000 |
750,000 |
|
- |
|
Lee Tom Y |
Chief Executive Officer |
|
2022-03-21 |
4 |
B |
$0.20 |
$36,630 |
D/D |
185,000 |
4,951,843 |
3.23 |
-0% |
|
Lee Tom Y |
Chief Executive Officer |
|
2022-03-17 |
4 |
B |
$0.18 |
$2,372 |
D/D |
13,250 |
4,766,843 |
3.15 |
9% |
|
Lee Tom Y |
Chief Executive Officer |
|
2022-03-16 |
4 |
B |
$0.18 |
$3,821 |
D/D |
21,227 |
4,753,593 |
3.15 |
17% |
|
Lee Tom Y |
Chief Executive Officer |
|
2021-06-16 |
4 |
B |
$0.43 |
$15,515 |
D/D |
35,998 |
4,732,366 |
2.81 |
-22% |
|
Rendall David |
Director |
|
2021-01-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
77,371 |
|
-35% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-12-24 |
4 |
B |
$0.65 |
$553 |
D/D |
851 |
4,696,368 |
2.73 |
-16% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-12-22 |
4 |
B |
$0.66 |
$29,988 |
D/D |
45,299 |
4,695,517 |
2.81 |
-13% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-12-21 |
4 |
B |
$0.68 |
$5,344 |
D/D |
7,859 |
4,650,218 |
2.81 |
-13% |
|
Okuno Dale |
Director |
|
2020-12-19 |
4 |
S |
$0.29 |
$217,175 |
D/D |
(748,880) |
5,560,540 |
|
13% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-12-17 |
4 |
B |
$0.65 |
$3,063 |
D/D |
4,712 |
4,642,359 |
2.73 |
-14% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-12-16 |
4 |
B |
$0.67 |
$13,300 |
D/D |
20,000 |
4,637,647 |
2.81 |
-14% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,732,222) |
13,401,951 |
|
- |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-22 |
4 |
B |
$1.72 |
$22,573 |
D/D |
13,124 |
4,617,647 |
2.81 |
-24% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-19 |
4 |
B |
$1.85 |
$18,500 |
D/D |
10,000 |
4,604,523 |
2.81 |
-32% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-18 |
4 |
B |
$1.75 |
$52,497 |
D/D |
30,000 |
4,594,523 |
2.81 |
-27% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-17 |
4 |
B |
$1.61 |
$43,136 |
D/D |
26,876 |
4,564,523 |
2.81 |
-19% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-16 |
4 |
B |
$1.62 |
$113,330 |
D/D |
70,000 |
4,537,647 |
2.81 |
-5% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-15 |
4 |
B |
$1.82 |
$109,200 |
D/D |
60,000 |
4,467,647 |
2.81 |
-24% |
|
Lee Tom Y |
Chief Executive Officer |
|
2020-06-12 |
4 |
B |
$1.91 |
$86,205 |
D/D |
45,157 |
4,407,647 |
2.81 |
-24% |
|
398 Records found
|
|
Page 1 of 16 |
|
|